HomeComparePKI vs LDOS

PKI vs LDOS: Dividend Comparison 2026

PKI yields 0.24% · LDOS yields 1.08%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 LDOS wins by $3.5K in total portfolio value
10 years
PKI
PKI
● Live price
0.24%
Share price
$115.24
Annual div
$0.28
5Y div CAGR
-50%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$19.7K
Annual income
$0.02
Full PKI calculator →
LDOS
LDOS
● Live price
1.08%
Share price
$154.19
Annual div
$1.66
5Y div CAGR
15.4%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$23.2K
Annual income
$520.20
Full LDOS calculator →

Portfolio growth — PKI vs LDOS

📍 LDOS pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodPKILDOS
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, PKI + LDOS cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
PKI pays
LDOS pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

PKI
Annual income on $10K today (after 15% tax)
$20.65/yr
After 10yr DRIP, annual income (after tax)
$0.02/yr
LDOS
Annual income on $10K today (after 15% tax)
$91.51/yr
After 10yr DRIP, annual income (after tax)
$442.17/yr
At 15% tax rate, LDOS beats the other by $442.15/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of PKI + LDOS for your $10,000?

PKI: 50%LDOS: 50%
100% LDOS50/50100% PKI
Portfolio after 10yr
$21.5K
Annual income
$260.11/yr
Blended yield
1.21%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on LDOS right now

PKI
Analyst Ratings
13
Buy
18
Hold
Consensus: Hold
Price Target
$166.57
+44.5% upside vs current
Range: $145.00 — $202.00
Altman Z
2.9
Piotroski
7/9
LDOS
Analyst Ratings
18
Buy
9
Hold
Consensus: Buy
Price Target
$211.29
+37.0% upside vs current
Range: $195.00 — $225.00
Altman Z
3.8
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

PKI buys
0
LDOS buys
0
No recent congressional trades found for PKI or LDOS in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricPKILDOS
Forward yield0.24%1.08%
Annual dividend / share$0.28$1.66
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR-50%15.4%
Portfolio after 10y$19.7K$23.2K
Annual income after 10y$0.02$520.20
Total dividends collected$24.00$2.8K
Payment frequencyquarterlyquarterly
SectorStockIndustrials
Analyst consensusHoldBuy
Analyst price target$166.57$211.29

Year-by-year: PKI vs LDOS ($10,000, DRIP)

YearPKI PortfolioPKI Income/yrLDOS PortfolioLDOS Income/yrGap
1← crossover$10,712$12.15$10,824$124.24$112.00LDOS
2$11,468$6.08$11,727$145.04$259.00LDOS
3$12,274$3.04$12,717$169.47$443.00LDOS
4$13,135$1.52$13,806$198.21$671.00LDOS
5$14,055$0.76$15,004$232.06$949.00LDOS
6$15,039$0.38$16,327$272.01$1.3KLDOS
7$16,092$0.19$17,789$319.22$1.7KLDOS
8$17,218$0.10$19,409$375.11$2.2KLDOS
9$18,424$0.05$21,209$441.40$2.8KLDOS
10$19,713$0.02$23,214$520.20$3.5KLDOS

PKI vs LDOS: Complete Analysis 2026

PKIStock

PerkinElmer, Inc. provides products, services, and solutions to the diagnostics, life sciences, and applied services markets worldwide. It operates through two segments, Discovery & Analytical Solutions and Diagnostics. The Discovery & Analytical Solutions segment offers a suite of solutions, including reagents, informatics, and detection and imaging technologies that enable scientists to enhance research breakthroughs in the life sciences research market, as well as contract research and laboratory services. It also provides analytical technologies, solutions, and services for the environmental, food, and industrial markets that enable its customers to understand the characterize the health of various aspects, including air, water, and soil. In addition, this segment offers solutions to farmers and food producers; and analytical instrumentation for the industrial market, which includes the chemical, semiconductor and electronics, energy, lubricant, petrochemical, and polymer industries. The Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market. Its products are used for testing and screening genetic abnormalities, disorders, and diseases, including down syndrome, hypothyroidism, muscular dystrophy, infertility, and various metabolic conditions. This segment also develops technologies that enable and support genomic workflows using protein coupled receptor and next-generation DNA sequencing for applications in oncology, immunodiagnostics, and drug discovery. It serves pharmaceutical and biotechnology companies, laboratories, academic and research institutions, public health authorities, private healthcare organizations, doctors, and government agencies. PerkinElmer, Inc. was founded in 1937 and is headquartered in Waltham, Massachusetts.

Full PKI Calculator →

LDOSIndustrials

Leidos Holdings, Inc., together with its subsidiaries, provides services and solutions in the defense, intelligence, civil, and health markets in the United States and internationally. It operates through three segments: Defense Solutions, Civil, and Health. The Defense Solutions segment offers national security solutions and systems for air, land, sea, space, and cyberspace for the U.S. Intelligence Community, the Department of Defense, the National Aeronautics and Space Administration, military services, and government agencies of U.S. allies abroad, as well as other federal and commercial customers in the national security industry. Its solutions include technology, large-scale systems, command and control platforms, data analytics, logistics, and cybersecurity solutions, as well as intelligence analysis and operations support services to critical missions. The Civil segment provides systems integration services to air navigation service providers, including the federal aviation administration, the En route automation modernization, advanced technology oceanic procedure, time based flow management, terminal flight data management, geo-7, and future flight services, as well as enterprise-information display systems; and security detection and automation services. It also offers information technology (IT) solutions in cloud computing, mobility, application modernization, DevOps, data center, network modernization, asset management, help desk operations, and digital workplace enablement; and environment, energy, and infrastructure services. The Health segment offers solutions to federal and commercial customers responsible for health and well-being of people worldwide, including health information management, managed health, digital transformation, and life sciences research and development services. Leidos Holdings, Inc. was founded in 1969 and is headquartered in Reston, Virginia.

Full LDOS Calculator →
📬

Get this PKI vs LDOS comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

PKI vs SCHDPKI vs JEPIPKI vs OPKI vs KOPKI vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.